ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
231.79
+0.62 (0.27%)
At close: Dec 24, 2024, 1:00 PM
232.58
+0.79 (0.34%)
After-hours: Dec 24, 2024, 5:00 PM EST

Company Description

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets.

The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights.

The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients’ device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal.

It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN’s software solutions.

The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force.

ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

ResMed Inc.
ResMed logo
Country United States
Founded 1989
IPO Date Jun 2, 1995
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 9,980
CEO Michael Farrell

Contact Details

Address:
9001 Spectrum Center Boulevard
San Diego, California 92123
United States
Phone 858-836-5000
Website resmed.com

Stock Details

Ticker Symbol RMD
Exchange NYSE
Fiscal Year July - June
Reporting Currency USD
CIK Code 0000943819
CUSIP Number 761152107
ISIN Number US7611521078
Employer ID 98-0152841
SIC Code 3841

Key Executives

Name Position
Michael J. Farrell BE, MBA, SM Chief Executive Officer and Chairman
Dr. Peter C. Farrell A.M., B.E., BE (Hons), Ph.D., ScD Founder, Chair Emeritus and Director
Brett A. Sandercock Chief Financial Officer
Michael J. Rider Chief Legal Officer and Secretary
Justin Leong Chief Product Officer
Kaushik Ghoshal Chief Commercial Officer - SaaS
Alastair Robertson Chief Information Officer
Jim Ellis Chief Compliance Officer
Yvonne-Katrin Pucknat Chief Marketing Officer
Vered Keisar Chief People Officer

Latest SEC Filings

Date Type Title
Dec 9, 2024 144 Filing
Dec 4, 2024 144 Filing
Dec 2, 2024 144 Filing
Nov 27, 2024 144 Filing
Nov 22, 2024 144 Filing
Nov 21, 2024 8-K Current Report
Nov 12, 2024 144 Filing
Nov 8, 2024 144 Filing
Nov 7, 2024 144 Filing
Nov 6, 2024 144 Filing